Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Pogue

Showing results (91-100 of 167) with videos related to

Pageof 17
Sort By:
International Journal of Antimicrobial Agents|January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changesRajnikant Sharma, Saloni Patel, Cely Abboud, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2018
Making the change to area under the curve-based vancomycin dosingEmily L Heil, Kimberly C Claeys, Ryan P Mynatt, et al.
Hospital Pharmacy|September 26, 2015
The State of Antimicrobial Stewardship in Michigan: Results of a Statewide Survey on Antimicrobial Stewardship Efforts in Acute Care HospitalsCurtis D Collins, Dianne E Miller, Rachel M Kenney, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactamsAva J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2017
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated NephrotoxicityNatalie A Finch, Evan J Zasowski, Kyle P Murray, et al.
Journal of Clinical Microbiology|December 20, 2019
Carbapenem-Susceptible Klebsiella pneumoniae and Escherichia coli Isolates Carrying a Truncated KPC Carbapenemase: a Challenge for Rapid Molecular DiagnosticsHossein Salimnia, Jennifer Veltman, Pranatharthi H Chandrasekar, et al.
BMC Infectious Diseases|September 27, 2025
Understanding the influence of religious and safety concerns on childhood measles and pertussis vaccination: a study conducted in Aceh, Indonesia, 2022Annie A Murphy, Rosaria Indah, Amanda Yufika, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxinsFlorian Wagenlehner, Ersilia Lucenteforte, Federico Pea, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremiaJason M Pogue, Ryan P Mynatt, Dror Marchaim, et al.
Pageof 17

Showing results (91-100 of 167) with videos related to

Sort By:
Pageof 17
International Journal of Antimicrobial Agents|January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changesRajnikant Sharma, Saloni Patel, Cely Abboud, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 19, 2018
Making the change to area under the curve-based vancomycin dosingEmily L Heil, Kimberly C Claeys, Ryan P Mynatt, et al.
Hospital Pharmacy|September 26, 2015
The State of Antimicrobial Stewardship in Michigan: Results of a Statewide Survey on Antimicrobial Stewardship Efforts in Acute Care HospitalsCurtis D Collins, Dianne E Miller, Rachel M Kenney, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2026
Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactamsAva J Dorazio, Ellen G Kline, Kevin M Squires, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2017
A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated NephrotoxicityNatalie A Finch, Evan J Zasowski, Kyle P Murray, et al.
Journal of Clinical Microbiology|December 20, 2019
Carbapenem-Susceptible Klebsiella pneumoniae and Escherichia coli Isolates Carrying a Truncated KPC Carbapenemase: a Challenge for Rapid Molecular DiagnosticsHossein Salimnia, Jennifer Veltman, Pranatharthi H Chandrasekar, et al.
BMC Infectious Diseases|September 27, 2025
Understanding the influence of religious and safety concerns on childhood measles and pertussis vaccination: a study conducted in Aceh, Indonesia, 2022Annie A Murphy, Rosaria Indah, Amanda Yufika, et al.
Antimicrobial Agents and Chemotherapy|April 26, 2017
<i>In Vitro</i> Assessment of Combined Polymyxin B and Minocycline Therapy against Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeDennis Huang, Brenda Yu, John K Diep, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 28, 2020
Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxinsFlorian Wagenlehner, Ersilia Lucenteforte, Federico Pea, et al.
Infection Control and Hospital Epidemiology|January 21, 2014
Automated alerts coupled with antimicrobial stewardship intervention lead to decreases in length of stay in patients with gram-negative bacteremiaJason M Pogue, Ryan P Mynatt, Dror Marchaim, et al.
Pageof 17